MedPath

Direct sputum sensitivity testing (DSST) in cystic fibrosis

Not Applicable
Completed
Conditions
Cystic fibrosis
Nutritional, Metabolic, Endocrine
Registration Number
ISRCTN61821827
Lead Sponsor
Department of Health (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Cystic fibrosis patients (with infective exacerbations requiring IV antibiotics) who are colonised with Pseudonomas or Burkholderia.

Exclusion Criteria

Does not meet inclusion criteria

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath